P3 Health Partners Inc.
NASDAQ:PIII
8.94 (USD) • At close April 25, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 1,500.455 | 1,266.375 | 1,049.5 | 491,063.525 | 485.541 | 145.482 | 87.697 |
| Cost of Revenue
| 0 | 1,234.74 | 1,144.513 | 668.066 | 485.298 | 141.03 | 0 |
| Gross Profit
| 1,500.455 | 31.635 | -95.013 | 490,395.459 | 0.244 | 4.452 | 87.697 |
| Gross Profit Ratio
| 1 | 0.025 | -0.091 | 0.999 | 0.001 | 0.031 | 1 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 112.596 | 122.362 | 157.3 | 53,390.338 | 53.39 | 36.424 | 28.542 |
| Selling & Marketing Expenses
| 1.331 | 3.233 | 5.1 | 1,502.634 | 1.503 | 0.802 | 1.87 |
| SG&A
| 113.927 | 125.595 | 162.4 | 54,892.972 | 54.893 | 37.225 | 30.412 |
| Other Expenses
| 1,707.186 | 73.97 | 1,133 | 464,758.231 | 465.769 | 147.793 | -0.104 |
| Operating Expenses
| 1,821.113 | 199.565 | 1,295.4 | 519,651.203 | 520.662 | 185.018 | 137.411 |
| Operating Income
| -320.658 | -167.86 | -1,560.9 | -31,411.542 | -35.121 | -39.536 | -49.715 |
| Operating Income Ratio
| -0.214 | -0.133 | -1.487 | -0.064 | -0.072 | -0.272 | -0.567 |
| Total Other Income Expenses Net
| 14.667 | -15.871 | 1.218 | -31,223.596 | -2.824 | -2.436 | -0.06 |
| Income Before Tax
| -305.991 | -183.731 | -1,559.6 | -31,411.542 | -45.382 | -41.972 | -49.774 |
| Income Before Tax Ratio
| -0.204 | -0.145 | -1.486 | -0.064 | -0.093 | -0.288 | -0.568 |
| Income Tax Expense
| 4.387 | 2.695 | 1.9 | -31,401.461 | -4 | 2.632 | -6.017 |
| Net Income
| -135.849 | -57.773 | -270.127 | -10.081 | -31.412 | -41.972 | -43.801 |
| Net Income Ratio
| -0.091 | -0.046 | -0.257 | -0 | -0.065 | -0.288 | -0.499 |
| EPS
| -0.94 | -0.61 | -6.5 | -0.24 | -0.79 | -0.88 | -0.64 |
| EPS Diluted
| -1.08 | -0.2 | -6.5 | -0.24 | -0.79 | -0.88 | -0.64 |
| EBITDA
| -242.106 | -81.071 | -1,461.002 | -184.615 | -28.083 | -39.039 | -49.372 |
| EBITDA Ratio
| -0.161 | -0.064 | -1.392 | -0 | -0.058 | -0.268 | -0.563 |